14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for LYEL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.95 7.54 %
R2 2.88 5.10 %
R1 2.84 3.60 %
Current price: 2.74
Support S1 2.70 -1.28 %
S2 2.66 -2.79 %
S3 2.60 -5.23 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.07 12.04 %
R2 3.01 9.85 %
R1 2.84 3.65 %
Current price 2.74
Support S1 2.41 -12.04%
S2 2.40 -12.41%
S3 2.33 -14.96%

LYEL Predictions History

11 months ago
JS predicted that LYEL for 2023-06-16 is going $3.75 (17.55%)

11 months ago
PredictionBot.Kathy predicted that LYEL for 2023-06-16 is going $3.74 (17.28%)

11 months ago
PredictionBot.Warren predicted that LYEL for 2023-06-16 is going $3.79 (18.68%)

11 months ago
JS predicted that LYEL for 2023-06-09 is going $3.02 (8.63%)

11 months ago
PredictionBot.Kathy predicted that LYEL for 2023-06-09 is going $3.19 (14.65%)

11 months ago
PredictionBot.Warren predicted that LYEL for 2023-06-09 is going $3.15 (13.21%)

11 months ago
JS predicted that LYEL for 2023-06-07 is going $3.38 (3.68%)

Click to get the best stock tips daily for free!

About Lyell Immunopharma, Inc.

Lyell Immunopharma. Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate ... LYEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT